Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT01859988 · COMPLETED
Trial details
- NCT number
- NCT01859988
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.